A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital. (2022). Asian Journal of Pharmaceutical and Health Sciences, 12(4), 2729-2738. https://doi.org/10.5530/ezagjy22